Roche

concept of computer chip and dollar sign
Biotech

Chugai inks $250M deal for Gero’s age-related disease targets

Chugai offered up to $250 million for the chance to develop antibodies against age-related disease targets identified by Gero's AI-driven platform.
Nick Paul Taylor Jul 7, 2025 3:00am
Redbrick building with Sarepta name and logo
Favicon Fierce Pharma

2nd patient dies after Sarepta's DMD gene therapy Elevidys

Jun 16, 2025 10:58am
Graphic showing arrows missing the bullseye on a target

How 'overenthusiasm' led to Big Pharma's risky $6B TIGIT gamble

Jun 13, 2025 8:00am
layoffs cut staff reduction workforce

Genentech lays off 143 workers at South San Francisco campus

Jun 11, 2025 12:25pm
Glowing puzzle piece fitting into puzzle

Vividion secures clinical-stage WRN inhibitor from Roche

Jun 4, 2025 9:21am
Businessman climbing steps to pluck a star from the sky

Roche links BTK drug to low relapse rate across 96-week MS trial

May 30, 2025 5:19am